Adding the anti-CD20 monoclonal antibody obinutuzumab (Gazyva) to standard therapy for lupus nephritis is more efficacious ...

Obinutuzumab B-cell depleting therapy is more effective than standard care in treating patients with active proliferative lupus nephritis.

Pedraza-Cruz, P. , Varghese, M. , DiGiacomo, D. , Spencer, C. and Horani, O. (2025) Adrenal Crisis Secondary to Bilateral Adrenal Hemorrhage in a Patient with Hypercoagulable Disorder. Case Reports in ...

Avoiding doing exercise moves incorrectly is exactly why Dr. Birnbaum says it’s recommended to work with a physical therapist when you start exercising. The physical therapist may recommend ...

China: A recent prospective cohort study has revealed that obesity significantly reduces the effectiveness of ...

A new study finds a strong link between gastroesophageal symptoms and higher rheumatoid arthritis (RA) disease activity, highlighting the need for symptom monitoring in RA management.

The FDA has accepted an investigational new drug application for ALLO-329, an allogeneic CAR T-cell therapy, paving the way for a phase 1 trial in lupus and other autoimmune diseases.

Interviews revealed what patients and their caregivers focus on and needed support throughout the CAR-T therapy trajectory.

An investigational therapy significantly shrank lung cancer tumors that are notoriously resistant to treatment by encouraging ...

Patients with CLE who have specific patient characteristics may have lower treatment response than patients who do not have these characteristics.

Interdisciplinary collaboration is key to reducing the risk for osteonecrosis of the jaw and improving patient care.

For patients with rheumatoid arthritis and inadequate response to JAK inhibitors, cycling to another JAK inhibitor is a more effective option than switching to a biological disease-modifying ...